65 related articles for article (PubMed ID: 16842753)
1. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity.
Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG
Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753
[TBL] [Abstract][Full Text] [Related]
2. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
[TBL] [Abstract][Full Text] [Related]
4. [The establishment of plasmid over-expressing mouse peroxisome proliferator-activated receptor gamma1 and functional identification in mesangial cells].
Sun J; Ma J; Hao CM; Gu Y; Lin SY
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2338-43. PubMed ID: 16321227
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
[TBL] [Abstract][Full Text] [Related]
6. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
[TBL] [Abstract][Full Text] [Related]
7. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
Turner JD; Schote AB; Keipes M; Muller CP
Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
[TBL] [Abstract][Full Text] [Related]
8. Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattle.
Roux M; Levéziel H; Amarger V
BMC Genomics; 2006 Apr; 7():71. PubMed ID: 16595010
[TBL] [Abstract][Full Text] [Related]
9. PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells.
Pang X; Shu Y; Niu Z; Zheng W; Wu H; Lu Y; Shen P
Exp Cell Res; 2014 Mar; 322(1):30-8. PubMed ID: 24440556
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
11. Ovary-specific novel peroxisome proliferator activated receptors-gamma transcripts in buffalo.
Sharma I; Monga R; Singh N; Datta TK; Singh D
Gene; 2012 Aug; 504(2):245-52. PubMed ID: 22609729
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor γ isoforms differentially regulate preadipocyte proliferation, apoptosis, and differentiation in chickens.
Mu F; Jing Y; Ning B; Huang J; Cui T; Guo Y; You X; Yan X; Li H; Wang N
Poult Sci; 2020 Dec; 99(12):6410-6421. PubMed ID: 33248556
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation.
Barz T; Hoffmann A; Panhuysen M; Spengler D
Cancer Res; 2006 Dec; 66(24):11975-82. PubMed ID: 17178896
[TBL] [Abstract][Full Text] [Related]
14. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.
Lui WO; Zeng L; Rehrmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Höög A; Larsson C; Kroll TG
Cancer Res; 2008 Sep; 68(17):7156-64. PubMed ID: 18757431
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions.
Nanjundan M; Zhang F; Schmandt R; Smith-McCune K; Mills GB
Oncogene; 2007 Apr; 26(18):2574-84. PubMed ID: 17072347
[TBL] [Abstract][Full Text] [Related]
16. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
Zheng S; Chen A
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
[TBL] [Abstract][Full Text] [Related]
17. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
[TBL] [Abstract][Full Text] [Related]
18. Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C.
Zhao J; Liu Z; Liu T; Nilsson S; Nistér M
Exp Cell Res; 2008 Aug; 314(14):2529-43. PubMed ID: 18588873
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Han S; Roman J
Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
